ClassID:

20918

A61K38/1709 - page 15 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#4201
20100247496
2010-09-30

Methods for treating cone dystrophy with neuronal viability factor, RDCVF2

#4202
20100240735
2010-09-23

Compositions and methods for angiogenic therapy utilizing genes encoding ets-1

#4203
20100239578
2010-09-23

MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR

#4204
20100239499
2010-09-23

Methods and compositions for genetic and retinal disease

#4205
20100235935
2010-09-16

Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof

#4206
20100234298
2010-09-16

Matrix protein compositions for induction of apoptosis

#4207
20100234274
2010-09-16

Use of Nestafin-1 in the Treatment for Diabetes

#4208
20100233735
2010-09-16

PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR

#4209
20100233249
2010-09-16

CONTRACEPTIVE METHODS AND COMPOSITIONS RELATED TO PROTEASOMAL INTERFERENCE

#4210
20100233137
2010-09-16

Compositions and Methods for Modification of Target Cells and to Their Uses Thereof

#4211
20100233127
2010-09-16

Targeted vectors for cancer immunotherapy

#4212
20100227817
2010-09-09

Method of treating ischemic injury with follistatin-like 1 polypeptide

#4213
20100227807
2010-09-09

Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis

#4214
20100226887
2010-09-09

BETA-2-GLYCOPROTEIN 1 IS AN INHIBITOR OF ANGIOGENESIS

#4215
20100226856
2010-09-09

Dynamic bio-nanoparticle elements

#4216
20100222401
2010-09-02

COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIC ANGIOGENESIS AND VASCULAR PERMEABILITY

#4217
20100221746
2010-09-02

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

#4218
20100221302
2010-09-02

Delivery system for heparin-binding growth factors

#4219
20100221208
2010-09-02

Treatment methods for fibrosis related disorders

#4220
20100216722
2010-08-26

USE OF THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS AS A THERAPEUTIC AGENT

#4221
20100216707
2010-08-26

Cosmetic use of apolipoprotein D type proteins

#4222
20100215660
2010-08-26

KRUPPEL-LIKE FACTORS AND FAT REGULATION

#4223
20100215640
2010-08-26

METHOD FOR INHIBITING CELLULAR ACTIVATION BY INSULIN-LIKE GROWTH FACTOR-1

#4224
20100215614
2010-08-26

Methods of using enterostatin as inhibitor of angiogenesis

#4225
20100212037
2010-08-19

MIA-2 PROTEIN

#4226
20100210523
2010-08-19

Modulation of activity of proneurotrophins

#4227
20100209526
2010-08-19

Product comprising a combination of milk serum apoproteins and free fatty acids

#4228
20100209444
2010-08-19

MAGE3 polypeptides

#4229
20100209346
2010-08-19

AMYLOID BETA(1-42) OLIGOMERS, DERIVATIVES THEREOF AND ANTIBODIES THERETO, METHODS OF PREPARATION THEREOF AND USE THEREOF

#4230
20100208290
2010-08-19

Deletion of unwanted reply messages in e-mail printing

#4231
20100204458
2010-08-12

Process for the production of immunogenic compositions

#4232
20100204453
2010-08-12

Antibodies to tumor associated proteins

#4233
20100204157
2010-08-12

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#4234
20100204152
2010-08-12

USE OF GLUTEN EXORPHIN C : AS A THERAPEUTIC AGENT

#4235
20100204144
2010-08-12

USE OF THE PEPTIDES MAIPPKKNQDK (COW KAPPA CASEIN 106-116) AND/OR YGFQNA (SERORPHIN) AS THERAPEUTIC AGENTS

#4236
20100204101
2010-08-12

Method and product for treatment and/or prevention of complications of prematurity

#4237
20100204099
2010-08-12

Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof

#4238
20100204093
2010-08-12

USE OF HEAT SHOCK ACTIVATORS FOR TISSUE REGENERATION

#4239
20100204087
2010-08-12

TRIBONECTINS

#4240
20100203526
2010-08-12

MECP2E1 gene

#4241
20100203103
2010-08-12

Method for inhibiting or reducing dry eye disease by IL-1Ra

#4242
20100203087
2010-08-12

Chemorepulsion of cells

#4243
20100197605
2010-08-05

THERAPEUTIC USE OF PEPTIDE YGLF AND COMBINATION WITH KVLPVPQ

#4244
20100191040
2010-07-29

Manipulation of ovarian primordial follicles

#4245
20100190720
2010-07-29

Compositions and methods for preventing or treating cancer

#4246
20100190702
2010-07-29

Compositions and methods of treating neoplasia

#4247
20100190692
2010-07-29

METHODS FOR REDUCING GNRH-POSITIVE TUMOR CELL PROLIFERATION

#4248
20100190195
2010-07-29

Use of Hepatitis B X-Interacting Protein (HBXIP) in Modulation of Apoptosis

#4249
20100189713
2010-07-29

Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation

#4250
20100189680
2010-07-29

Methods of Treating Various Cancers Using Melanoma Differentiating Associated Protein-7

#4251
20100184697
2010-07-22

Peptide-based stat inhibitor

#4252
20100184691
2010-07-22

Method for treating heart failure by inhibiting the sarcolemmal sodium/calcium exchange

#4253
20100184662
2010-07-22

Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis

#4254
20100184651
2010-07-22

TARGETED FUSION PROTEINS FOR CANCER THERAPY

#4255
20100184636
2010-07-22

Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor

#4256
20100183749
2010-07-22

TOPICALLY ACTIVE STEROIDS FOR USE IN RADIATION AND CHEMOTHERAPEUTICS INJURY

#4257
20100183723
2010-07-22

Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same

#4258
20100183706
2010-07-22

PEPTIDE EPITOPES OF APOLIPOPROTEIN B

#4259
20100183702
2010-07-22

Therapies for cancer using RLIP76

#4260
20100183666
2010-07-22

METHODS OF REDUCING PAPILLOMAVIRUS INFECTION USING IMMUNOMODULATORY POLYNUCLEOTIDE SEQUENCES

#4261
20100183640
2010-07-22

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION

#4262
20100183617
2010-07-22

COMPOSITIONS AND METHODS FOR REGULATING SAS1R

#4263
20100183608
2010-07-22

Chimeric DRG11-responsive (DRAGON) polypetides

#4264
20100183587
2010-07-22

Methods for reducing corneal nerves damage, corneal lymphangiogenesis or immunity to corneal antigens in dry-eye associated ocular surface diseases by IL-1Ra

#4265
20100173840
2010-07-08

Pharmaceutical Composition for Treating Autoimmune, Allergic and Inflammatory Diseases and Delivery Method Thereof

#4266
20100173829
2010-07-08

Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof

#4267
20100173385
2010-07-08

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof

#4268
20100173314
2010-07-08

DIAGNOSTIC METHODS USING TENASCIN-W COMPOSITIONS

#4269
20100168025
2010-07-01

Treatment of stroke using domain V of perlecan

#4270
20100166827
2010-07-01

Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration

#4271
20100166777
2010-07-01

HEMATOPOIETIC CELLS THAT EXPRESS MOSC-1

#4272
20100166707
2010-07-01

EXTRACELLULAR MATRIX/METASTASIS MODIFIER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR

#4273
20100160618
2010-06-24

Expanding the eukaryotic genetic code

#4274
20100160232
2010-06-24

Physiologically active complex comprising protamine and/or salt therefor and an acidic macromolecular substance, and use thereof

#4275
20100158975
2010-06-24

Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions

#4276
20100158856
2010-06-24

Assays and methods using biomarkers

#4277
20100151588
2010-06-17

MEANS AND METHODS FOR DIAGNOSING AND TREATING CANCER BASED ON THE FRMD3 GENE

#4278
20100151051
2010-06-17

Anti-tumor drug, medicament, composition, and use thereof

#4279
20100146649
2010-06-10

Purkinje cell-tropic viral vector

#4280
20100144849
2010-06-10

METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF

#4281
20100144627
2010-06-10

Methods for decreasing set in inhibiting protein phosphatase 2A (PP2A) and/or increasing the activity of cyclin-dependent kinase 5 (CDK5) by an APOE peptide

#4282
20100144618
2010-06-10

Compositions containing an intestinal trefoil peptide and a mucoadhesive

#4283
20100144603
2010-06-10

METHODS AND USES THEREOF OF PROSAPOSIN

#4284
20100144012
2010-06-10

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#4285
20100143444
2010-06-10

Peptides and peptide mimetics to treat pathologies associated with eye disease

#4286
20100143416
2010-06-10

Alpha-defensins as anthrax immunotherapeutics

#4287
20100143333
2010-06-10

Method of treating diabetes

#4288
20100143317
2010-06-10

Infarct area perfusion-improving compositions and methods of vascular injury repair

#4289
20100143309
2010-06-10

Viral vectors

#4290
20100137224
2010-06-03

Method of reducing injury to mammalian cells

#4291
20100137210
2010-06-03

Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor

#4292
20100137205
2010-06-03

Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation

#4293
20100137201
2010-06-03

MEDICAMENTS

#4294
20100136087
2010-06-03

Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition

#4295
20100130413
2010-05-27

Treatment for age-related macular degeneration and other diseases of the eye

#4296
20100130412
2010-05-27

Method of treatment of type-1 diabetes with a humanin analogue

#4297
20100130411
2010-05-27

Method for treating cartilage disorders

#4298
20100130405
2010-05-27

Biglycan and related therapeutics and methods of use

#4299
20100129316
2010-05-27

Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors

#4300
20100120892
2010-05-13

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

#4301
20100120863
2010-05-13

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

#4302
20100120667
2010-05-13

COMPOSITION FOR PREVENTING AND/OR TREATING PEPTIC ULCERS

#4303
20100119551
2010-05-13

Methods and reagents for vaccination which generate a CD8 T cell immune response

#4304
20100119495
2010-05-13

Human skin equivalents expressing exogenous polypeptides

#4305
20100113398
2010-05-06

Treatment and/or Prevention of Non-Viral Epithelial Damage

#4306
20100113354
2010-05-06

THERAPEUTIC AGENT COMPRISING VASOHIBIN

#4307
20100113343
2010-05-06

METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES

#4308
20100111908
2010-05-06

Induction of Renal Cells for Treatment of Kidney Disease

#4309
20100105070
2010-04-29

Diagnosis and treatment of preeclampsia

#4310
20100104541
2010-04-29

Method for preventing and treating cardiovascular diseases with BRCA1

#4311
20100099747
2010-04-22

REDUCTION OF POLYALANINE-INDUCED PROTEIN AGGREGATES AND TOXICITY BY UBIQUILIN

#4312
20100099619
2010-04-22

Pancreatic polypeptide family motifs, polypeptides and methods comprising the same

#4313
20100099607
2010-04-22

Casein complexes

#4314
20100099605
2010-04-22

Chaperonin 10 immunosuppression

#4315
20100098703
2010-04-22

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

#4316
20100098682
2010-04-22

Effect of Bri Proteins on Ass Production

#4317
20100098680
2010-04-22

Anti-pathogen treatments

#4318
20100093840
2010-04-15

Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy

#4319
20100093626
2010-04-15

PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES IN DISEASE

#4320
20100093621
2010-04-15

SCGB3A2 as a growth factor and anti-apoptotic agent

#4321
20100087514
2010-04-08

METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS

#4322
20100087362
2010-04-08

USE OF BIGLYCAN OR ENHANCERS OF BIGLYCAN ACTIVITY IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS

#4323
20100086610
2010-04-08

Vault and vault-like carrier molecules

#4324
20100080848
2010-04-01

Recombinant lubricin molecules and uses thereof

#4325
20100080820
2010-04-01

Preparation of a therapeutic composition

#4326
20100076062
2010-03-25

Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

#4327
20100075900
2010-03-25

Use of Nutritional Compositions for Preventing Disorders

#4328
20100074935
2010-03-25

Recombinant lubricin molecules and uses thereof

#4329
20100069466
2010-03-18

Compositions and methods for the systemic treatment of arthritis

#4330
20100068201
2010-03-18

Compositions and methods for the systemic treatment of arthritis

#4331
20100068177
2010-03-18

Methods of organ regeneration using Hox11-expressing pluripotent cells

#4332
20100068149
2010-03-18

Use of nutritional compositions for preventing disorders

#4333
20100068141
2010-03-18

USE OF HEAT SHOCK TO TREAT OCULAR DISEASE

#4334
20100061997
2010-03-11

Transgenic non-human animals expressing a truncated activin type II receptor

#4335
20100056608
2010-03-04

METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3, AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2

#4336
20100056455
2010-03-04

Therapies which act on neuropeptide S receptors

#4337
20100056446
2010-03-04

Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases

#4338
20100056431
2010-03-04

MEDICAL USES

#4339
20100055786
2010-03-04

METHOD FOR TREATING KIDNEY DISORDERS

#4340
20100048484
2010-02-25

Methods for treating diabetic wounds

#4341
20100048471
2010-02-25

Angiogenesis inhibitor comprising meteorin as an active ingredient

#4342
20100048458
2010-02-25

Tribonectins

#4343
20100047330
2010-02-25

TREATMENT FOR DARK ADAPTATION

#4344
20100041867
2010-02-18

Reversible pegylated drugs

#4345
20100041142
2010-02-18

ANTI-APOPTOTIC GENE SCC-S2 AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

#4346
20100040639
2010-02-18

Methods of inducing IL-10 production

#4347
20100035815
2010-02-11

Skin wound healing compositions and methods of use thereof

#4348
20100034824
2010-02-11

TARGETED BIOCIDES

#4349
20100034802
2010-02-11

TREATMENT OF PAIN

#4350
20100034788
2010-02-11

Method for diagnosing and treating bone-related diseases

#4351
20100034772
2010-02-11

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

#4352
20100031377
2010-02-04

Prevention and treatment of synucleinopathic and amyloidogenic disease

#4353
20100028924
2010-02-04

Method Of Diagnosing Pon1-Hdl Associated Lipid Disorders

#4354
20100028360
2010-02-04

METHODS FOR THE MODULATION OF BRAIN PROGESTAGEN SIGNALING IN THE PREVENTION AND TREATMENT OF NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES

#4355
20100028332
2010-02-04

Antagonists of actriib and uses for increasing red blood cell levels

#4356
20100028331
2010-02-04

Antagonists of activin-actriia and uses for increasing red blood cell levels

#4357
20100028302
2010-02-04

Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions

#4358
20100022442
2010-01-28

COMPOSITIONS AND METHODS FOR INCREASING SERUM ANTIOXIDANT CONCENTRATIONS, DECREASING SERUM TRIGLYCERIDE LEVELS, INHIBITING INSULIN-RECEPTOR SIGNALING ACTIVITY, INCREASING SERUM GHRELIN LEVELS, AND DECREASING SERUM TNF-ALPHA LEVELS

#4359
20100021488
2010-01-28

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

#4360
20100021485
2010-01-28

Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases

#4361
20100021462
2010-01-28

GASP1: a follistatin domain containing protein

#4362
20100021453
2010-01-28

Targeting of triacylclycerol synthase gene for tuberculosis treatment

#4363
20100021428
2010-01-28

Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)

#4364
20100021422
2010-01-28

METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVOUS SYSTEM SITES

#4365
20100017901
2010-01-21

Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use

#4366
20100016938
2010-01-21

Diagnosing, monitoring and treating inflammation

#4367
20100016413
2010-01-21

Pathotropic targeted gene delivery system for cancer and other disorders

#4368
20100016241
2010-01-21

METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION

#4369
20100016235
2010-01-21

Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof

#4370
20100016222
2010-01-21

Agent for inducing apoptosis comprising MSX1 or a gene encoding the same as an active ingredient

#4371
20100016218
2010-01-21

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#4372
20100015130
2010-01-21

DISC-1 pathway activators in the control of neurogenesis

#4373
20100015126
2010-01-21

Methods of Binding of Cross-Beta Structures By Chaperones

#4374
20100015099
2010-01-21

Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system

#4375
20100015091
2010-01-21

MODIFIED STAT1 TRANSGENE THAT CONFERS INTERFERON HYPERRESPONSIVENESS, METHODS AND USES THEREFOR

#4376
20100009919
2010-01-14

Apolipoprotein A1 mimetics and uses thereof

#4377
20100009903
2010-01-14

Methods for promoting wound healing and/or reducing scar formation

#4378
20100008931
2010-01-14

Coronin 1 modulators for the treatment of autoimmune and Lymphoproliferative disorders and mycobacterial infections

#4379
20100004430
2010-01-07

Antibodies against a peptide epitope of apolipoprotein B

#4380
20100004172
2010-01-07

Compositions for mucosal and oral administration comprising hcg fragments

#4381
20100004171
2010-01-07

Therapeutic Methods for Neuropathic Pain

#4382
20100004168
2010-01-07

Use of Crystallin For The Modulation of Angiogenesis

#4383
20100004166
2010-01-07

Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic Diseases

#4384
20100003225
2010-01-07

HSP60, HSP60 peptides and T cell vaccines for immunomodulation

#4385
20100003218
2010-01-07

Hybrid-AAV vectors to deliver large gene expression cassette

#4386
20090325882
2009-12-31

Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion

#4387
20090325868
2009-12-31

Materials and methods for FOXP3 tumor suppression

#4388
20090325170
2009-12-31

Means and methods for diagnosing and/or treating a subject at risk of developing heart failure

#4389
20090324733
2009-12-31

Composition of Whey Growth Factor Extract for Reducing Muscle Inflammation

#4390
20090324677
2009-12-31

Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1

#4391
20090324632
2009-12-31

Methods and reagents for vaccination which generate a CD8 T cell immune response

#4392
20090317393
2009-12-24

METHOD OF MODIFYING GLUCOSE ACTIVITY USING POLYPEPTIDES SELECTIVELY EXPRESSED IN FAT TISSUE

#4393
20090312258
2009-12-17

USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES

#4394
20090312257
2009-12-17

USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES

#4395
20090312256
2009-12-17

USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES

#4396
20090312245
2009-12-17

SRA binding protein

#4397
20090312238
2009-12-17

Protection Against Oxidative Damage in Cells

#4398
20090311281
2009-12-17

NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID

#4399
20090311236
2009-12-17

Therapeutic Peptide Compositions And Methods Of Making And Using Same

#4400
20090311224
2009-12-17

THERAPEUTIC AGENT COMPRISING LIPOCALIN 2 AGAINST CANCER METASTASIS, AND METHODS OF EARLY DIAGNOSIS AND INHIBITION OF CANCER METASTASIS USING LIPOCALIN 2

#4401
20090311213
2009-12-17

Methods and compositions for treatment of retinoid-responsive conditions

#4402
20090308392
2009-12-17

Dry powder inhaler and system for drug delivery

#4403
20090308391
2009-12-17

Dry powder inhaler and system for drug delivery

#4404
20090308390
2009-12-17

Dry powder inhaler and system for drug delivery

#4405
20090306030
2009-12-10

Methods of inhibiting osteoclast activity

#4406
20090305992
2009-12-10

USE OF AN INTERLEUKIN 1 RECEPTOR ANTAGONIST AND/OR PYRROLIDINEDITHIOCARBAMATE FOR THE TREATMENT OR PROPHYLAXIS OF TYPE 2 DIABETES

#4407
20090305982
2009-12-10

Muteins of tear lipocalin and methods for obtaining the same

#4408
20090305981
2009-12-10

Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers

#4409
20090305966
2009-12-10

Use of histones for therapeutic purposes

#4410
20090305946
2009-12-10

Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory

#4411
20090304781
2009-12-10

MASTER GENE OF ARTERIOGENESIS

#4412
20090304765
2009-12-10

R-RAS activity in vascular regulation

#4413
20090304691
2009-12-10

Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof

#4414
20090304664
2009-12-10

Modulators of alpha-synuclein toxicity

#4415
20090304663
2009-12-10

USE OF GSK-3 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER

#4416
20090304650
2009-12-10

Repair of the Bone Marrow Vasculature

#4417
20090304642
2009-12-10

Methods of specifying mesodermal, endodermal and mesoendodermal cell fates

#4418
20090304597
2009-12-10

Use of an active biological substance in abnormal cellular and viral membrane physiologies

#4419
20090298772
2009-12-03

Therapeutics to inhibit MLL-menin interaction for treating leukemia

#4420
20090298771
2009-12-03

USE OF SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME

#4421
20090298759
2009-12-03

C-reactive protein and its use to treat systemic lupus erythematosus and related conditions

#4422
20090298741
2009-12-03

Trophic factor combinations for nervous system treatment

#4423
20090297538
2009-12-03

Neurotoxic oligomers

#4424
20090297528
2009-12-03

Methods to identify compounds useful for the treatment of proliferative and differentiative disorders

#4425
20090297511
2009-12-03

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#4426
20090291091
2009-11-26

USE OF THE GLOBULAR DOMAIN OF ACRP30 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF THROMBOSIS-RELATED DISEASES

#4427
20090291086
2009-11-26

Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia

#4428
20090291060
2009-11-26

Treatment of HIV

#4429
20090286857
2009-11-19

Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders

#4430
20090286741
2009-11-19

Methods for improving the structure and function of arterioles

#4431
20090286726
2009-11-19

Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases

#4432
20090281037
2009-11-12

Method of reducing injury to mammalian cells

#4433
20090281026
2009-11-12

Use of BiP or a variant, homologue, derivative or fragment thereof in the manufacture of a medicament for the prevention or treatment of bone loss or bone resorption

#4434
20090281024
2009-11-12

Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof

#4435
20090281019
2009-11-12

Methods for treating atrial or ventricular arrhythmias

#4436
20090280227
2009-11-12

Method of making a molded food item from individual food pieces

#4437
20090280126
2009-11-12

Antibodies against a peptide epitope of apolipoprotein B

#4438
20090280081
2009-11-12

JAK/STAT pathway inhibitors and uses thereof

#4439
20090280071
2009-11-12

Use of repeat sequence protein polymers in personal care compositions

#4440
20090275884
2009-11-05

Use of nucleic acids with reduced pressure therapy

#4441
20090275521
2009-11-05

Regulation of Microphage Migration Inhibitory Factor (MIF) Activity

#4442
20090275516
2009-11-05

Method for treating rheumatoid arthritis using anti-S100A9 antibody

#4443
20090275508
2009-11-05

Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection

#4444
20090275134
2009-11-05

Compositions of active Wnt protein

#4445
20090274651
2009-11-05

Therapeutic agent for infections, and treatment method using the same

#4446
20090270321
2009-10-29

Over-expression of MPS-1 gene or its gene product(s) results in reduction in size of a variety of malignancies

#4447
20090270320
2009-10-29

Use of galectin-7 to promote the re-epithelialization of wounds

#4448
20090270313
2009-10-29

Method of treatment for ischemic heart disease

#4449
20090263404
2009-10-22

Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor

#4450
20090258830
2009-10-15

Diagnostic and therapeutic uses of gelsolin in renal failure

#4451
20090258829
2009-10-15

NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN

#4452
20090258794
2009-10-15

APOPTOSIS METHODS, GENES AND PROTEINS

#4453
20090258032
2009-10-15

Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity

#4454
20090257952
2009-10-15

Engineered integrin binding peptides

#4455
20090253622
2009-10-08

USE OF TLR3 AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

#4456
20090253619
2009-10-08

Novel peptide involved in energy homeostasis

#4457
20090252808
2009-10-08

Controlled release of biological entities

#4458
20090252717
2009-10-08

Compositions and Methods for Treating Polyglutamine-Expansion Neurodegenerative Diseases

#4459
20090246333
2009-10-01

Method and device for producing shaped meat portions from whole natural meat pieces

#4460
20090246189
2009-10-01

Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons

#4461
20090246150
2009-10-01

Antimicrobial composition

#4462
20090239802
2009-09-24

Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof

#4463
20090238864
2009-09-24

DNA vaccines encoding heat shock proteins

#4464
20090238810
2009-09-24

OPHTHALMIC COMPOSITION

#4465
20090233893
2009-09-17

Methods of Dissolving Beta-Sheet Proteins and Uses Thereof

#4466
20090233867
2009-09-17

Treatment of ocular wounds and ulcers

#4467
20090233865
2009-09-17

Nutritional compositions

#4468
20090233859
2009-09-17

Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

#4469
20090233854
2009-09-17

NOVEL APPLICATION OF APELIN

#4470
20090232910
2009-09-17

Biomarkers and therapeutics targets for cognitive decline

#4471
20090232876
2009-09-17

In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide

#4472
20090232783
2009-09-17

Method for regulating production of hemoglobin beta chains

#4473
20090227531
2009-09-10

Transcription factors in neuronal dendrites-dendritic protein synthesis and cell death

#4474
20090227518
2009-09-10

COMPOSITIONS AND METHODS FOR TREATING ACTIN-MEDIATED MEDICAL CONDITIONS

#4475
20090227501
2009-09-10

Agents for preventing and/or treating upper digestive tract disorders

#4476
20090227489
2009-09-10

STAT3 Agonists and Antagonists and Therapeutic Uses Thereof

#4477
20090227023
2009-09-10

DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh

#4478
20090226475
2009-09-10

PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS

#4479
20090226460
2009-09-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

#4480
20090226454
2009-09-10

Antibodies against a peptide epitope of apoliporotein B

#4481
20090226427
2009-09-10

NOVEL PHARMACEUTICAL COMPOSITIONS FOR MODULATING ANGIOGENESIS

#4482
20090222938
2009-09-03

Therapeutic Target Molecules For The Development of Novel Medicaments for Degenerative Diseases

#4483
20090220581
2009-09-03

Methods of reducing inflammation and mucus hypersecretion

#4484
20090220512
2009-09-03

Genes and polypeptides relating to prostate cancers

#4485
20090220507
2009-09-03

INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE

#4486
20090220482
2009-09-03

Methods and compositions for delivering interleukin-1 receptor antagonist

#4487
20090220453
2009-09-03

Enhancing stem cell mobilization

#4488
20090215984
2009-08-27

Conversion of apoptotic proteins

#4489
20090215690
2009-08-27

Compositions and methods for inhibiting cell migration

#4490
20090215684
2009-08-27

Use of BPI Protein for Treatment of Diseases

#4491
20090215666
2009-08-27

VIVIT POLYPEPTIDES, THERAPEUTIC AGENT COMPRISING THE SAME, AND METHOD OF SCREENING FOR ANTI-CANCER AGENT

#4492
20090215665
2009-08-27

Compositions and methods for promoting wound healing and tissue regeneration

#4493
20090215147
2009-08-27

Use of mutant Herpes Simplex Virus-2 for cancer therapy

#4494
20090214637
2009-08-27

Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity

#4495
20090214612
2009-08-27

EXTRACELLULAR TNF INHIBITORS FOR TREATING CNS DISORDERS

#4496
20090214540
2009-08-27

Protein involved in cancer

#4497
20090214538
2009-08-27

Use of complement inhibitors to treat ocular diseases

#4498
20090214514
2009-08-27

GUS3 NEUROPEPTIDES FOR REGULATING HYPOTHALAMIC FUNCTION

#4499
20090214480
2009-08-27

Cancer antigen peptide and the use thereof

#4500
20090214473
2009-08-27

COMBINATION CHAPERONIN 10 AND BETA-INTERFERON THERAPY FOR MULTIPLE SCLEROSIS